Quick Summary — HSTM scores higher on quality with 9.0/10 vs NRC's 7.2/10. HSTM trades at $25.22 while NRC trades at $19.59. Both analyzed daily using SEC EDGAR data across 13 institutional models.
HSTM scores higher with a 9.0/10 quality rating vs NRC's 7.2/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.
At $25.22, HSTM trades +11.1% above its Bayesian DCF fair value of $22.41, while NRC at $19.59 trades +62.3% above its estimate of $7.38. NRC shows a wider gap between price and intrinsic value.
HSTM earns a Quality of Company score of 9.0/10 compared to NRC's 7.2/10. This moderate difference suggests one company has an edge in fundamental quality, though both may offer investment merit depending on valuation. The QOC score synthesizes 32 signals spanning profitability margins, revenue growth, free cash flow, capital allocation, and leverage.
HSTM carries a SAFE value trap risk (17/100) while NRC shows SAFE risk (14/100). Both companies show manageable value trap risk, suggesting their current valuations are not artificially depressed by fundamental deterioration.
Both HSTM and NRC operate in Health Information Services, which has 46 stocks tracked by CirclFi. Same-industry comparisons provide the most direct insight into relative valuation since both companies face similar regulatory environments, market dynamics, and competitive pressures. Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN), and ensemble methods (CUCE).
11 hidden models compare HSTM vs NRC differently — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more. Some may disagree with the 2 you see above.
Bloomberg Terminal: ~$2,000/mo · FactSet: ~$1,000/mo · CirclFi: $0.90/day
See All 13 Models — $0.90/dayWe don’t predict prices. We show you what 13 independent mathematical frameworks say a stock is worth — and let you decide.